🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’re hiring - virtual research coordinator. Get involved with an innovative & disruptive digital health company. Our aim is to improve health and wellbeing by connecting people to research opportunities on a global scale. Learn more opyl.ai/services/caree…

We are so pleased to receive this in the mail today - HIPPA compliance for @Opin_Health our clinical trial recruitment solution. Congratulations team Dr Nicola Straiton (she/her) Nick Lam @AnthonyDPMPro Anna Chen 🙌🏻 $OPL #datasecurity #dataprivacy

Podcast alert: Our first $OPL podcast dropped today, featuring CEO Michelle Gallaher & CTO Damon Rasheed discussing TrialKey - our novel #AI approach to improving #clincialtrial protocols, setting trials and studies up for success. The next one is on GPT3 opylpod.podbean.com/e/trialkey/

Congrats Antonio Jimeno Yepes - we are all so proud to share in this celebration with you and RMIT School of Computing Technologies karin verspoor (professor) RMIT University 🥂

Curious about how #AI is impacting #clinicaltrials? Come over and listen to the chat between our CEO Michelle Gallaher and CTO Damon Rasheed in our first podcast of the OpylPod series. 22 minutes podbean.com/ew/pb-yymvr-13…

Excited to welcome a new team member to Opyl today, Naz Haidari - Social Media and Marketing Coordinator 🙌🏻 #TeamOpyl

Our collaborator ⁦karin verspoor (professor)⁩ delivered a fantastic foundation presentation on #ChatGPT demystifying and clarifying language models. We are using ChatGPT with ⁦@Opin_Health⁩ making #clinicaltrials more accessible and equitable youtu.be/gbznDIf13qM

$OPL announces the appointment of Dr Hugo Stephenson as an advisor. Dr Stephenson brings global experience in commercialising clinical trial data management platforms and trial efficiency solutions.tinyurl.com/3nvumfdu

Minister for Health and Medical Research Mary-Anne Thomas MP highlight the leadership and value of investing in #clinicaltrials in Victoria. Our CEO Michelle Gallaher is speaking on the panel at AmCham Australia lunch today about @Opin_Health and how AI is improving trials 🙌🏻 $OPL

#PodcastAlert In celebration of #ClinicalTrialsDay #CTD2023 Michelle Gallaher discusses #consent, #technology and participation barriers, with Dr Rebecca Saunderson of Consentic podbean.com/ew/pb-tpwnx-14…

#PodcastAlert In celebration of #ClinicalTrialsDay #CTD2023 Michelle Gallaher discusses #clinicalsites and the #participantexperience, with Dr Megan Robertson of @StVincentsMelb podbean.com/ew/pb-dubwz-14…

#PodcastAlert In celebration of #ClinicalTrialsDay #CTD2023 Michelle Gallaher discusses the #CRO challenge in a post-pandemic world, with the fantastic Sharon Charles of ProPharma podbean.com/ew/pb-va95a-14…

📢 Exciting news! Opyl CEO Michelle Gallaher will share insights on #ClinicalTrial data collection & evidence generation, regulatory considerations, & clinical trial efficiency at #AusMedTech tomorrow. Join her session in Room L2 at the Adelaide Convention Centre at 4:15 pm.

Opin is a global website designed to help people find and take part in health and medical research. Visit opin.ai to find research studies near you. #ClinicalTrials #MedicalResearch

#PodcastAlert The last in our series celebrating #ClinicalTrialsDay #CTD2023 International Clinical Trials Day: The evolving roles of patient advocacy and health research, with James Stewart of Pancare Foundation podbean.com/eas/pb-z57ks-1…

Thrilled to be at #AusMedtech23 ⁦AusBiotech⁩ with Naz Haidari, our ⁦Opyl⁩ team mate based in South Australia #TeamOpyl ⁦@Opin_Health⁩ #Clinicaltrialrecruitment

See how we're applying #AI to improve #clinicaltrial design, ensuring more discoveries make it to the clinic. Opyl CEO Michelle Gallaher will showcase TrialKey for the 1st time, demonstrating how we're saving time & billions of $$ @futuremetaconf futuresconference.com.au

Opyl’s TrialKey achieves major milestone with potential to improve #clinicaltrial success rates ⁦Stockhead⁩ $OPL #AiHealth stockhead.com.au/health/opyls-t…

There are so many ways in which AI is impacting and improving clinical trial inputs and outcomes. From patient identification and selection ⁦@Opin_Health⁩ through to XAI #clinicaltrial design ⁦TrialKey⁩ - great article from SaxonAI saxon.ai/blogs/empoweri…

🔊 @Opin_Health, Opyl's health #research recruitment specialists, are delighted to announce the release of a new, free #report: Outlook for Australia & New Zealand Clinical Trials 2024! Download it here: opin.ai/resources/outl…